SynthesisUpdates in surgery2026
Cutting-edge choices: comparative outcomes of laparoscopic vs robotic cholecystectomy-a systematic review.
Synthesis in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally invasive techniques, particularly laparoscopic cholecystectomy (LC) and robotic-assisted cholecystectomy (RAC), are now the mainstays in the surgical management of gallbladder diseases. Both techniques are widely used, but there is a paucity of comparative studies with regards to surgical efficacy, cost, and patient recovery time. This meta-analysis aims to compare their key differences to improve clinical practice and outcomes. A PRISMA-compliant systematic review was conducted of peer-reviewed comparative studies evaluating LC versus RAC for benign gallbladder disease. Outcomes included conversion to open surgery, operative time, complication rates, postoperative length of stay, postoperative pain, and cost-effectiveness. Random-effects meta-analysis was performed where appropriate.Six studies were included. RAC was associated with significantly lower odds of conversion to open surgery than LC (OR 0.10, 95% CI 0.01-0.94; p = 0.04), although this finding was based on sparse retrospective data. RAC was associated with longer operative time in the available comparative data. No significant difference was found in postoperative length of stay (MD 0.38 days, 95% CI -0.06 to 0.82; p = 0.09) or overall complication rates (OR 0.57, 95% CI 0.04-7.79; p = 0.67). Pain outcomes were reported using non-standardized measures, limiting firm interpretation. Most studies suggested RAC was more costly than LC, although findings varied by institutional setting and costing method. RAC may reduce conversion to open surgery in selected settings, but broader clinical benefit over LC remains uncertain. Overall, LC remains the more established and economically justifiable approach for most patients undergoing cholecystectomy for benign gallbladder disease, while further high-quality prospective studies are needed to clarify the role of RAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.